Wang Xiaochuan Baichuan Intelligent has set up a technology company in Ningbo with a number of AI businesses. According to enterprise investigation, recently, Ningbo Baichuan Ronghui Technology Co., Ltd. was established with Wang Xiaochuan as the legal representative and a registered capital of 70 million US dollars. Its business scope includes artificial intelligence dual-creation service platform, artificial intelligence theory and algorithm software development, artificial intelligence basic software development, artificial intelligence general application system, artificial intelligence public data platform and artificial intelligence public service platform technical consulting service. Equity penetration shows that the company is wholly owned by BAICHUAN AI (HK) LIMITED.Lu Kang led a delegation to visit the United States and had an in-depth exchange of views with people from all walks of life on Sino-US relations. From December 1 to 7, Lu Kang, Vice Minister of the International Liaison Department of the CPC Central Committee, led a delegation to visit the United States. In Washington, new york, and San Francisco, Lu Kang met with officials from the White House and the State Council, members of Congress, and relevant people from business circles, think tanks, media, universities, societies, enterprises, etc., and exchanged in-depth views on Sino-US relations. (official website of the International Liaison Department)The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.
Consumer stocks in Hong Kong stocks fluctuated higher, with the same journey rising by more than 6%, Mengniu Dairy rising by more than 4%, and China Resources Beer, Master Kong Holdings and Haidilao rising.Hang Seng Science and Technology Index rose to 1%, while Kewang shares rose, with Billie Billie (09626.HK) rising by over 4%, Baidu (09888.HK) rising by 2.8%, Aauto Quicker (01024.HK), Tencent Holdings (00700.HK) rising by 1.8% and Alibaba (09988.HK) rising by over 1%.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.
Treasury futures rose by 0.30%, the 30-year main contract rose by 0.30%, and the 30-year main contract rose by 0.30%, a record high. The 10-year main contract rose by 0.12%, the 5-year main contract rose by 0.05% and the 2-year main contract rose by 0.02%.Shanghai's state-owned assets reform index rose, with the daily limit of First Medicine, Yimin Group, Kaikai Industry and Shanghai Phoenix, and Shanghai 900 rose by more than 8%.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide